Just one place in Australia is hitting hepatitis B treatment targets — this is what it does
When Australia missed its target of treating 20% of chronic hepatitis B patients in 2022, there was one exception. Even in 2023, the national treatment…
When Australia missed its target of treating 20% of chronic hepatitis B patients in 2022, there was one exception. Even in 2023, the national treatment…
A GP expert says this year’s early influenza surge is unsurprising but disappointing as it can be explained partly by Australia’s low vaccination rates. More…
A leading infectious diseases specialist has urged GPs to prescribe nirmatrelvir–ritonavir more readily for patients in aged care facilities, who are still dying of COVID-19…
Patients with COVID-19 will be restricted to telehealth consultations with their regular practice from 1 July after Medicare scraps their exemption to the existing relationship…
Nirmatrelvir-ritonavir is no better than placebo for resolving symptoms in patients who are at low risk for severe COVID-19, results from an international study suggest.…
The Federal Government has rejected a proposal that pharmacists be allowed to sell antiviral treatments for COVID-19 over the counter, saying it would be illegal…
The PBAC has warned that the $981 million annual cost of subsiding COVID-19 antivirals must be curbed with stricter PBS criteria or price cuts for the manufacturers. …
NSW Minister for Health Ryan Park has confirmed that the state’s pharmacy trial will be expanded to allow pharmacists to prescribe treatments for four skin conditions including…
“I live a very different life now.” This is Melbourne oncologist Dr Bronwyn King describing what two bouts of COVID-19 did to her and how they…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.